These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22934553)

  • 21. Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanisms.
    Vergès B
    Diabetes Metab; 2020 Nov; 46(6):442-449. PubMed ID: 32998054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The functioning of hormone-sensitive adenylyl cyclase system in the peripheral tissiues in diabetes mellitus].
    Shpakov AO; Derkach KV
    Tsitologiia; 2014; 56(2):91-104. PubMed ID: 25509148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate immunity, Toll-like receptors, and atherosclerosis: mouse models and methods.
    Sorrentino R; Arditi M
    Methods Mol Biol; 2009; 517():381-99. PubMed ID: 19378021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metainflammation in Diabetic Coronary Artery Disease: Emerging Role of Innate and Adaptive Immune Responses.
    Aravindhan V; Madhumitha H
    J Diabetes Res; 2016; 2016():6264149. PubMed ID: 27610390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upper limb musculoskeletal abnormalities and poor metabolic control in diabetes.
    Ramchurn N; Mashamba C; Leitch E; Arutchelvam V; Narayanan K; Weaver J; Hamilton J; Heycock C; Saravanan V; Kelly C
    Eur J Intern Med; 2009 Nov; 20(7):718-21. PubMed ID: 19818294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The innate immune system, toll-like receptors and dermal wound healing: A review.
    Portou MJ; Baker D; Abraham D; Tsui J
    Vascul Pharmacol; 2015 Aug; 71():31-6. PubMed ID: 25869514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of Toll-like receptors in immune disorders.
    Uematsu S; Akira S
    Expert Opin Biol Ther; 2006 Mar; 6(3):203-14. PubMed ID: 16503731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular disease in diabetes.
    Bloomgarden ZT
    Diabetes Care; 2010 Apr; 33(4):e49-54. PubMed ID: 20351221
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of Toll-like receptor pathways in the mechanism of type 1 diabetes.
    Lien E; Zipris D
    Curr Mol Med; 2009 Feb; 9(1):52-68. PubMed ID: 19199942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes.
    Tai N; Wong FS; Wen L
    J Autoimmun; 2016 Jul; 71():26-34. PubMed ID: 27021275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic regulation of Toll-like receptors and its roles in type 1 diabetes.
    Xie Z; Huang G; Wang Z; Luo S; Zheng P; Zhou Z
    J Mol Med (Berl); 2018 Aug; 96(8):741-751. PubMed ID: 30003291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-like receptor 2/4 links to free fatty acid-induced inflammation and β-cell dysfunction.
    Yin J; Peng Y; Wu J; Wang Y; Yao L
    J Leukoc Biol; 2014 Jan; 95(1):47-52. PubMed ID: 24018354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Excess risk of lower extremity amputations in people with type 1 diabetes compared with the general population: amputations and type 1 diabetes.
    Ólafsdóttir AF; Svensson AM; Pivodic A; Gudbjörnsdottir S; Nyström T; Wedel H; Rosengren A; Lind M
    BMJ Open Diabetes Res Care; 2019; 7(1):e000602. PubMed ID: 31114696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like receptors regulate B cell cytokine production in patients with diabetes.
    Jagannathan M; McDonnell M; Liang Y; Hasturk H; Hetzel J; Rubin D; Kantarci A; Van Dyke TE; Ganley-Leal LM; Nikolajczyk BS
    Diabetologia; 2010 Jul; 53(7):1461-71. PubMed ID: 20383694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innate immunity and its role in type 1 diabetes.
    Zipris D
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):326-31. PubMed ID: 18594272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-Inflammatory Effect of Exercise Mediated by Toll-Like Receptor Regulation in Innate Immune Cells - A Review.
    Collao N; Rada I; Francaux M; Deldicque L; Zbinden-Foncea H
    Int Rev Immunol; 2020; 39(2):39-52. PubMed ID: 31682154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Janus Kinase 3 in Predisposition to Obesity-associated Metabolic Syndrome.
    Mishra J; Verma RK; Alpini G; Meng F; Kumar N
    J Biol Chem; 2015 Dec; 290(49):29301-12. PubMed ID: 26451047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
    van der Linden MW; Plat AW; Erkens JA; Emneus M; Herings RM
    Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of toll-like receptors in diabetic kidney disease.
    Panchapakesan U; Pollock C
    Curr Opin Nephrol Hypertens; 2018 Jan; 27(1):30-34. PubMed ID: 29059081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleic Acid-Sensing Toll-Like Receptors Play a Dominant Role in Innate Immune Recognition of Pneumococci.
    Famà A; Midiri A; Mancuso G; Biondo C; Lentini G; Galbo R; Giardina MM; De Gaetano GV; Romeo L; Teti G; Beninati C
    mBio; 2020 Mar; 11(2):. PubMed ID: 32209688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.